• Blog
  • Fiducial Markers Market Growth Analysis | 2023-2028

    Fiducial Markers Market Growth Analysis | 2023-2028

    Fiducial Markers Market Growth Analysis | 2023-2028
    Report code - SRHL272 Delivery - 2 Weeks
    Fiducial Markers Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis - 2 See more...

    Market Insights

    The fiducial markers market was estimated at USD 118.38 million in 2022 and is likely to grow at a CAGR of 4.28% during 2023-2028 to reach USD 152.77 million in 2028.

    Fiducial-Markers-Market-Insights

    Wish to get a free sample report? Click Here.

    What is a fiducial marker?

    A fiducial marker is a medical device that is mainly placed on the object or body so that it can mark the area that needs surgery. These markers are very tiny equipment of the size of rice grains, which can help to target cancerous tumours or tissues without affecting the healthy ones. This device enables to mark off the exact position of the tumour and can help the doctor to provide maximum radiation dose to the particular area consisting of the tumour without harming the surrounding tissues.

    COVID-19 IMPACT

    The outbreak of the COVID-19 virus has moderately affected the fiducial markers industry owing to stringent lockdown measures and restricted movement of people. The ongoing coronavirus pandemic has adversely altered the healthcare landscape.

    As major healthcare companies accelerate efforts to discover potential vaccines and drugs for COVID-19, immense pressure is being exerted across global hospital infrastructures. In spite of this, the market for fiducial markers has remained strong due to unceasing cancer treatments. However, some of the treatments were postponed or canceled.

    Fiducial Markers Market Highlights

    Market Size in 2022

    USD 118.38 million

    Market Size in 2028

    USD 152.77 million

    Market Growth (2023-2028)

    4.34% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2022

    Forecast Period

    2023-2028

    Key Players

    Key players operating in the fiducial markers market are-

    • CIVCO Radiotherapy (The U.S),
    • IZI Medical Products (The U.S),
    • Naslund Medical AB (Sweden),
    • Medtronic, Inc. (Ireland),
    • QlRad Inc. (Netherlands),
    • QFix (The U.S),
    • Boston Scientific Corporation (The U.S),
    • Nanovi A/S (Denmark),
    • Eckert & Ziegler (Belgium), and
    • IBA Dosimetry GmbH (Germany).

    Market Dynamics

    The growing adoption of radiotherapy devices by oncologists coupled with rising cases of cancer across the globe are the prime factors augmenting the product demand. Also, the surging demand for SBRT and IGRT procedures further boosts market growth.

    Moreover, increasing awareness regarding the fiducial markers to give effective diagnosis further offers lucrative opportunities to the industry players. However, the requirement of placing fiducial markers before the CT scan will necessitate a second 3D scan before or during surgery can hamper the industry expansion.

    Fiducial-Markers-Market-Dynamics

    Want to have a closer look at this market report? Register Here

    Segment Analysis

    By Product Trends

    By product, the fiducial markers market has been categorized into gold, gold combination, polymer, other metals, and liquid.

    Under these, the gold segment witnessed the highest market share in 2022 and is likely to register a significant CAGR during the review period.

    This is mainly attributed to the accurate visibility and excellent stability of these products across various imaging modalities. Also, gold fiducial markers come in combination with various metals, such as platinum, titanium, and nickel, for better efficiency.

    Regional Trends

    By region, the North American market garnered the largest market share in 2022 and is projected to grow at a substantial CAGR during the assessment period.

    This is mainly ascribed to streamlined reimbursement policies, the strong presence of key market players, and public health programs in the region. Growing healthcare expenditure and rising adoption of advanced radiotherapy procedures & imaging modalities further boost regional growth.

    Fiducial-Markers-Market-Regional-Trends

    Know the high-growth countries in this report. Register Here

    Critical Questions Answered in the Report

    • What are the key trends in the fiducial markers market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories.

    By Product Type

    • Gold
    • Gold Combination
    • Polymer
    • Other Metals
    • Liquid

    By Modality Type

    • CT/CBCT
    • MRI
    • Ultrasound
    • X-Ray

    By Application Type

    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Head, and Neck Cancer
    • Others

    By End-Use Type

    • Hospitals
    • Radiotherapy Center
    • Academic
    • Research Center

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Fiducial-Markers-Market-Segmentation

    Click Here, to learn the market segmentation details.

    Target Audience

    The following is a list of the customers that the fiducial markers market aims to convert the most:

    • Fiducial Markers companies
    • Fiducial Markers vendors
    • R&D companies
    • Hospitals
    • Cancer organizations

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Fiducial Markers Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the application types by modality type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The fiducial markers market is expected to witness an impressive growth of 4.28% CAGR in the foreseeable future.

    CIVCO Radiotherapy (The U.S), IZI Medical Products (The U.S), Naslund Medical AB (Sweden), Medtronic, Inc. (Ireland), QlRad Inc. (Netherlands), QFix (The U.S), Boston Scientific Corporation (The U.S), Nanovi A/S (Denmark), Eckert & Ziegler (Belgium) and IBA Dosimetry GmbH (Germany) are among the key players in the market.

    The fiducial markers market size is expected to reach USD 152.77 million in the coming years.

    North America garnered the largest share in the fiducial markers market in 2022..

    The gold segment witnessed the highest share of the market in 2022.

    The growing adoption of radiotherapy devices by oncologists coupled with rising cases of cancer across the globe, and increasing awareness regarding the fiducial markers to give effective diagnosis are the factors driving the growth of the market.

    Fiducial Markers companies, Fiducial Markers vendors, R&D companies, Hospitals, Cancer organizations are the target audience in the market.